VICTORIA, June 19, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), a licensed producer to cultivate and sell marijuana under the Marihuana for Medical Purposes Regulations (Canada), is pleased to announce that the Company has changed its name to "Emerald Health Therapeutics Inc.", as approved by the board of directors of the Company and the TSX Venture Exchange. Effective June 23, 2015, the Company's shares will begin trading on the TSX Venture Exchange under the new symbol "EMH".
Emerald Health Therapeutics Inc.
Emerald Health Therapeutics, Inc. wholly owns Emerald Health Botanicals Inc. (formerly Thunderbird Biomedical Inc.) Emerald Health Botanicals Inc. was the fifth company in Canada to receive a License under the Marihuana for Medical Purposes Regulations (Canada) to cultivate and sell medical cannabis out of its facility located in Victoria, British Columbia. For more information please visit: www.emerald.care.
ON BEHALF OF THE BOARD
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and sales of medical marijuana, anticipated revenues, projected size of market, quantities of future medical marijuana production, completion of production facilities and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Emerald Health Therapeutics, Inc. (the "Company") does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, results of production and sale activities, the Company's historical experience with medical marijuana operations, uninsured risks, regulatory changes, availability of production facilities, timeliness of government approvals and the granting of permits and licenses, changes in prices, actual operating and financial performance of facilities, equipment and processes relative to specifications and expectations. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE Emerald Health Therapeutics Inc.
For further information: Kam Thindal at 604-488-9875 or firstname.lastname@example.org